ArticleJournal of molecular structure2022

Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors.

Reaz Uddin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.